Specificity of light and electron microscopic features of hypertrophic obstructive and nonobstructive cardiomyopathy.

European Heart Journal
|November 1, 1983
PubMed

Insights

Hypertrophic cardiomyopathy involves abnormal heart muscle growth. A new theory suggests embryonic hypercontractility causes hyperplasia, leading to asymmetric septal thickening and symptoms after birth.

Area of Science:

  • Cardiovascular Pathology
  • Developmental Biology
  • Cardiac Histology

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by abnormal thickening of the heart muscle.
  • Histologic and ultrastructural abnormalities are key features in HCM.
  • Myocardial fiber disarray is observed in HCM, but also in other conditions to a lesser extent.

Purpose of the Study:

  • To review histologic and ultrastructural abnormalities in hearts of patients with hypertrophic cardiomyopathy.
  • To propose a new theory of morphogenesis for asymmetric cardiac hypertrophy in HCM.
  • To explain the developmental basis of septal asymmetry and progressive hypertrophy in HCM.

Main Methods:

  • Review of existing literature on histologic and ultrastructural findings in hypertrophic cardiomyopathy.
  • Analysis of myocardial fiber disarray prevalence in HCM versus other conditions.
  • Formulation of a novel theory based on cellular and developmental mechanisms.

Main Results:

  • Myocardial fiber disarray is a common finding in HCM, exceeding 5% of myocytes in transverse ventricular septum sections.
  • A proposed theory posits embryonic hypercontractility as the primary stimulus for inappropriate cardiac mass increase in HCM.
  • This stimulus leads to hyperplasia (increased cell number) during embryonic development, particularly in the ventricular septum, causing exaggerated asymmetric growth.

Conclusions:

  • Postnatal septal asymmetry in HCM fails to regress due to pre-existing hyperplasia, unlike in normal individuals.
  • A subsequent postnatal phase involves myocyte hypertrophy (enlargement), further exaggerating septal thickening and leading to clinical symptoms.
  • The proposed theory integrates embryonic hyperplasia and postnatal hypertrophy to explain the pathogenesis of hypertrophic cardiomyopathy.

Related Concept Videos

Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...